ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 5,500 shares of the stock in a transaction dated Tuesday, July 8th. The stock was sold at an average price of $19.57, for a total transaction of $107,635.00. Following the completion of the sale, the chief executive officer directly owned 147,000 shares in the company, valued at $2,876,790. This trade represents a 3.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
ReposiTrak Price Performance
TRAK stock traded up $0.12 during mid-day trading on Wednesday, reaching $19.76. The company had a trading volume of 58,581 shares, compared to its average volume of 63,236. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03. The company has a market capitalization of $361.21 million, a P/E ratio of 58.12 and a beta of 0.51. ReposiTrak Inc. has a 12 month low of $15.72 and a 12 month high of $25.01.
ReposiTrak Cuts Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Monday, June 30th will be paid a $0.0182 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a yield of 0.37%. ReposiTrak's dividend payout ratio is currently 20.59%.
Hedge Funds Weigh In On ReposiTrak
An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC grew its stake in ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,289 shares of the company's stock after acquiring an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 at the end of the most recent reporting period. 27.35% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of ReposiTrak from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.
Check Out Our Latest Stock Analysis on ReposiTrak
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Further Reading
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
